Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Less Known but Clinically Relevant Comorbidities of Atrial Fibrillation: A Narrative Review

Author(s): Goran Koraćević, Milan Stojković, Milovan Stojanović*, Marija Zdravković, Dragan Simić, Sonja Šalinger-Martinović, Dragan Đorđević, Miodrag Damjanović, Danijela Đorđević-Radojković and Maja Koraćević

Volume 20, Issue 5, 2022

Published on: 19 September, 2022

Page: [429 - 438] Pages: 10

DOI: 10.2174/1570161120666220819095215

Price: $65

Abstract

Background: The important risk factors for atrial fibrillation (AF) in the general population are not always equally important in specific and relatively prevalent diseases.

Objective: The main goal of this narrative review is to focus attention on the presence and the relationship of AF with several important diseases, such as cancer or sepsis, in order to: 1) stimulate further research in the field, and 2) draw attention to this relationship and search for AF in clinical practice.

Methods: We searched PubMed, SCOPUS, Elsevier, Wiley, Springer, Oxford Journals, Cambridge, SAGE, and Google Scholar for less-known comorbidities of AF. The search was limited to publications in English. No time limits were applied.

Results: AF is widely represented in cardiovascular and other important diseases, even in those in which AF is rarely mentioned. In some specific clinical subsets of AF patients (e.g., patients with sepsis or cancer), the general risk factors for AF may not be so important. Patients with new-onset AF have a several-fold increase in relative risk of cancer, deep vein thrombosis, and pulmonary thromboembolism (PTE) during the follow-up.

Conclusion: AF presence, prognosis, and optimal therapeutic approach are insufficiently recognised in several prevalent diseases, including life-threatening ones. There is a need for a better search for AF in PTE, pulmonary oedema, aortic dissection, sepsis, cancer and several gastrointestinal diseases. Improved AF detection would influence treatment and improve outcomes.

Keywords: Atrial fibrillation, pulmonary embolism, aortic dissection, sepsis, cancer, pulmonary oedema.

« Previous Next »
Graphical Abstract

[1]
Heeringa J, van der Kuip DAM, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006; 27(8): 949-53.
[http://dx.doi.org/10.1093/eurheartj/ehi825] [PMID: 16527828]
[2]
Weng LC, Preis SR, Hulme OL, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation 2018; 137(10): 1027-38.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.031431] [PMID: 29129827]
[3]
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130(23): 2071-104.
[http://dx.doi.org/10.1161/CIR.0000000000000040] [PMID: 24682348]
[4]
Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33(21): 2719-47.
[http://dx.doi.org/10.1093/eurheartj/ehs253] [PMID: 22922413]
[5]
Andersson T, Magnuson A, Bryngelsson IL, et al. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients. Int J Cardiol 2014; 177(1): 91-9.
[http://dx.doi.org/10.1016/j.ijcard.2014.09.092] [PMID: 25499348]
[6]
Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NA III. The state of the art: Atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc 2016; 91(12): 1778-810.
[http://dx.doi.org/10.1016/j.mayocp.2016.08.022] [PMID: 27825618]
[7]
Guenancia C, Binquet C, Laurent G, et al. Incidence and predictors of new-onset atrial fibrillation in septic shock patients in a medical ICU: Data from 7-day Holter ECG monitoring. PLoS One 2015; 10(5): e0127168.
[http://dx.doi.org/10.1371/journal.pone.0127168] [PMID: 25965915]
[8]
Walkey AJ, Greiner MA, Heckbert SR, et al. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: Incidence and risk factors. Am Heart J 2013; 165(6): 949-955.e3.
[http://dx.doi.org/10.1016/j.ahj.2013.03.020] [PMID: 23708166]
[9]
Bosch NA, Cohen DM, Walkey AJ. Risk factors for new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis. Crit Care Med 2019; 47(2): 280-7.
[http://dx.doi.org/10.1097/CCM.0000000000003560] [PMID: 30653473]
[10]
Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review. Crit Care 2014; 18(6): 688.
[http://dx.doi.org/10.1186/s13054-014-0688-5] [PMID: 25498795]
[11]
Fauchier L, Samson A, Chaize G, et al. Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: A nationwide database study. Open Heart 2015; 2(1): e000290.
[http://dx.doi.org/10.1136/openhrt-2015-000290] [PMID: 26688739]
[12]
Ferreira C, Providência R, Ferreira MJ, Gonçalves LM. Atrial fibrillation and non-cardiovascular diseases: A systematic review. Arq Bras Cardiol 2015; 105(5): 519-26.
[http://dx.doi.org/10.5935/abc.20150142] [PMID: 26577719]
[13]
Koyfman L, Brotfain E, Kutz R, et al. Epidemiology of new-onset paroxysmal atrial fibrillation in the General Intensive Care Unit population and after discharge from ICU. A retrospective epidemiological study. Anaesthesiol Intensive Ther 2015; 47(4): 309-14.
[http://dx.doi.org/10.5603/AIT.a2015.0040] [PMID: 26210522]
[14]
Aibar J, Schulman S. New-onset atrial fibrillation in sepsis: A narrative review. Semin Thromb Hemost 2021; 47(1): 18-25.
[http://dx.doi.org/10.1055/s-0040-1714400] [PMID: 32968991]
[15]
Induruwa I, Hennebry E, Hennebry J, Thakur M, Warburton E, Khadjooi K. Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation? Eur J Intern Med 2021; S0953-6205(21): 00361-7.
[16]
Xiao FP, Chen MY, Wang L, et al. Outcomes of new-onset atrial fibrillation in patients with sepsis: A systematic review and meta-analysis of 225,841 patients. Am J Emerg Med 2021; 42: 23-30.
[http://dx.doi.org/10.1016/j.ajem.2020.12.062] [PMID: 33429188]
[17]
Koracevic G, Atanaskovic V. Is atrial fibrillation a prognosticator in acute pulmonary thromboembolism? Med Princ Pract 2010; 19(2): 166.
[http://dx.doi.org/10.1159/000273082] [PMID: 20134183]
[18]
Koraćević G, Janković–Tomašević R, Dimitrijević E, et al. Atrial fibrillation doubled in-hospital mortality in 1379 acute cardiogenic pulmonary edema patients. Facta Univ Ser Med Biol 2016; 17(1): 33-5.
[19]
Koracevic G, Djordjevic D, Glasnovic J. Is significance of atrial fibrillation in acute aortic dissection underestimated? J Emerg Med 2009; 37(2): 168-70.
[http://dx.doi.org/10.1016/j.jemermed.2007.11.094] [PMID: 18554844]
[20]
Koracevic GP. Cancer is an insufficiently recognized risk factor for atrial fibrillation. J Emerg Med 2012; 42(3): 312-3.
[http://dx.doi.org/10.1016/j.jemermed.2010.05.080] [PMID: 20851556]
[21]
Weber DM, Phillips JH. The prognostic value of supraventricular arrhythmias in acute pulmonary embolism. Vasc Dis 1966; 3(6): 393-7.
[PMID: 5928425]
[22]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6(7): e1000097.
[http://dx.doi.org/10.1371/journal.pmed.1000097] [PMID: 19621072]
[23]
Ma M, Shi J, Feng X, Wang J, Liu L, Wei X. The elevated admission white blood cell count relates to adverse surgical outcome of acute Stanford type a aortic dissection. J Cardiothorac Surg 2020; 15(1): 48.
[http://dx.doi.org/10.1186/s13019-020-1078-5] [PMID: 32171309]
[24]
Chew HC, Lim SH. Aortic dissection presenting with atrial fibrillation. Am J Emerg Med 2006; 24(3): 379-80.
[http://dx.doi.org/10.1016/j.ajem.2005.11.001] [PMID: 16635726]
[25]
Fuster V, Rydén LE, Cannom DS, et al. Orientações de 2006 da ACC/AHA/ESC para o tratamento de doentes com fibrilhação auricular--sumário executivo. Rev Port Cardiol 2007; 26(4): 383-446.
[PMID: 17695733]
[26]
Mehta RH, Dabbous OH, Granger CB, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003; 92(9): 1031-6.
[http://dx.doi.org/10.1016/j.amjcard.2003.06.001] [PMID: 14583352]
[27]
Hu WS, Lin CL. Bidirectional association between aortic dissection and atrial fibrillation: Findings from a huge national database. Clin Cardiol 2019; 42(9): 812-9.
[http://dx.doi.org/10.1002/clc.23223] [PMID: 31292982]
[28]
Blanco BA, Kothari AN, Halandras PM, et al. Transient atrial fibrillation after open abdominal aortic revascularization surgery is associated with increased length of stay, mortality, and readmission rates. J Vasc Surg 2017; 66(2): 413-22.
[http://dx.doi.org/10.1016/j.jvs.2016.11.036] [PMID: 28190713]
[29]
Shiraishi Y, Kohno T, Egashira T, et al. Thrombus in acute aortic dissection with atrial fibrillation: A treatment dilemma. Am J Emerg Med 2015; 33(2): 308.e3-4.
[http://dx.doi.org/10.1016/j.ajem.2014.07.040] [PMID: 25214031]
[30]
Stöllberger C, Schäffl-Doweik L, Korn M, Finsterer J. Atrial fibrillation and stroke as initial manifestations of painless type A aortic dissection. Neurol Neurochir Pol 2017; 51(6): 507-9.
[http://dx.doi.org/10.1016/j.pjnns.2017.07.008] [PMID: 28803639]
[31]
Lourenco S, Neves Z, Pacheco MH, Malhado JA. Disección aórtica aguda indolora: El reto de un diagnóstico difícil en un paciente con insuficiencia cardíaca. Med Intensiva 2011; 35(7): 446-7.
[http://dx.doi.org/10.1016/j.medin.2010.12.001] [PMID: 21333387]
[32]
Chang RY, Kan CB, Yan YH. Ruptured aortic dissection presenting with new onset atrial fibrillation. BMJ Case Rep 2012; 2012: bcr2012007417.
[http://dx.doi.org/10.1136/bcr-2012-007417] [PMID: 23175019]
[33]
Ciulla MM, Vivona P, Lemos A, Sozzi F, Cioffi U, Testori A. Atrial fibrillation, an epiphenomenon of acute Stanford type-A aortic dissection with suspected intimo-intimal intussusception. Clin Case Rep 2018; 6(9): 1791-4.
[http://dx.doi.org/10.1002/ccr3.1701] [PMID: 30214765]
[34]
Li LY, Lin HC, Lee CY, Hsu YP. Acute aortic occlusion in a patient with atrial fibrillation and aortic dissection. Intern Med 2012; 51(20): 2983-4.
[http://dx.doi.org/10.2169/internalmedicine.51.8548] [PMID: 23064582]
[35]
Ptaszynska-Kopczynska K, Kiluk I, Sobkowicz B. Atrial fibrillation in patients with acute pulmonary embolism: clinical significance and impact on prognosis. BioMed Res Int 2019; 2019: 7846291.
[http://dx.doi.org/10.1155/2019/7846291] [PMID: 31531368]
[36]
Bikdeli B, Abou Ziki MD, Lip GYH. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A Systematic Review. Semin Thromb Hemost 2017; 43(8): 849-63.
[http://dx.doi.org/10.1055/s-0036-1598005] [PMID: 28196379]
[37]
Enga KF, Rye-Holmboe I, Hald EM, et al. Atrial fibrillation and future risk of venous thromboembolism: the Tromsø study. J Thromb Haemost 2015; 13(1): 10-6.
[http://dx.doi.org/10.1111/jth.12762] [PMID: 25330989]
[38]
Bikdeli B, Jiménez D. Atrial fibrillation in the course of pulmonary embolism: Just a little smoke, or fuel to the fire? J Intern Med 2020; 287(1): 114-6.
[http://dx.doi.org/10.1111/joim.12999] [PMID: 31637791]
[39]
Krajewska A, Ptaszynska-Kopczynska K, Kiluk I, et al. Paroxysmal atrial fibrillation in the course of acute pulmonary embolism: Clinical significance and impact on prognosis. BioMed Res Int 2017; 2017: 5049802.
[http://dx.doi.org/10.1155/2017/5049802] [PMID: 28280732]
[40]
Kukla P, McIntyre WF, Koracevic G, et al. Relation of atrial fibrillation and right-sided cardiac thrombus to outcomes in patients with acute pulmonary embolism. Am J Cardiol 2015; 115(6): 825-30.
[http://dx.doi.org/10.1016/j.amjcard.2014.12.049] [PMID: 25638519]
[41]
Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail 2019; 7(6): 447-56.
[http://dx.doi.org/10.1016/j.jchf.2019.03.005] [PMID: 31146871]
[42]
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82(8A): 2N-9N.
[http://dx.doi.org/10.1016/S0002-9149(98)00583-9] [PMID: 9809895]
[43]
Labbaoui M, Doyen D, Squara F, Ferrari E. Incidence, clinical features, and long-term outcomes of new-onset atrial fibrillation in the intensive care unit: A prospective observational study. Arch Cardiovasc Dis Suppl 2020; 12(1): 117.
[http://dx.doi.org/10.1016/j.acvdsp.2019.09.256]
[44]
Koracevic G, Cvetkovic E, Tomasevic M, et al. Atrial fibrillation doubled in-hospital mortality in 1397 acute cardiogenic pulmonary edema patients. Circulation 2010; 122(2): E228-8.
[45]
Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: The Belgrade Atrial Fibrillation Study. Eur J Heart Fail 2013; 15(4): 415-24.
[http://dx.doi.org/10.1093/eurjhf/hft004] [PMID: 23302606]
[46]
Long MT, Ko D, Arnold LM, et al. Gastrointestinal and liver diseases and atrial fibrillation: A review of the literature. Therap Adv Gastroenterol 2019; 12: 1756284819832237.
[http://dx.doi.org/10.1177/1756284819832237] [PMID: 30984290]
[47]
Niederseer D, Hammerl S, Kahr PC, et al. Patients with atrial fibrillation have a significantly increased prevalence of advanced premalignant adenomas and colorectal cancer in screening colonoscopy. Z Gastroenterol 2018; 56(05): V03.
[48]
Farooq MZ, Mukthinuthalapati VPK, Lateef N, et al. Association of atrial fibrillation with colorectal and breast cancer: A systematic review and meta-analysis. J Clin Oncol 2019; 37(15): e13096.
[http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e13096]
[49]
Roh JH, Lee JH, Lee H, et al. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults. Liver Int 2020; 40(2): 338-46.
[http://dx.doi.org/10.1111/liv.14236] [PMID: 31479572]
[50]
Mantovani A, Dauriz M, Sandri D, et al. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis. Liver Int 2019; 39(4): 758-69.
[http://dx.doi.org/10.1111/liv.14044] [PMID: 30657626]
[51]
Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis. Clin Res Hepatol Gastroenterol 2017; 41(5): 525-32.
[http://dx.doi.org/10.1016/j.clinre.2017.08.001] [PMID: 28866089]
[52]
Ding YH, Ma Y, Qian LY, et al. Linking atrial fibrillation with non-alcoholic fatty liver disease: Potential common therapeutic targets. Oncotarget 2017; 8(36): 60673-83.
[http://dx.doi.org/10.18632/oncotarget.19522] [PMID: 28948002]
[53]
Laliberté F, Moore Y, Dea K, et al. Gastrointestinal comorbidities associated with atrial fibrillation. Springerplus 2014; 3(1): 603.
[http://dx.doi.org/10.1186/2193-1801-3-603] [PMID: 25392776]
[54]
Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004; 110(9): 1042-6.
[http://dx.doi.org/10.1161/01.CIR.0000140263.20897.42] [PMID: 15313941]
[55]
Lip GY, Laroche C, Dan GA, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: Baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 2014; 16(3): 308-19.
[http://dx.doi.org/10.1093/europace/eut373] [PMID: 24351881]
[56]
García Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998; 158(1): 33-9.
[http://dx.doi.org/10.1001/archinte.158.1.33] [PMID: 9437376]
[57]
Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol 2010; 24(2): 109-20.
[http://dx.doi.org/10.1016/j.bpg.2009.11.006] [PMID: 20227025]
[58]
Keller M, Meierhenrich R. Neu aufgetretenes Vorhofflimmern beim septischen Patienten. Anaesthesist 2017; 66(10): 786-94.
[http://dx.doi.org/10.1007/s00101-017-0334-0] [PMID: 28660415]
[59]
Rath B, Niehues P, Leitz P, Eckardt L. Vorhofflimmern bei nichtkardialen infektionen und sepsis. Herzschrittmacherther Elektrophysiol 2019; 30(3): 256-61.
[http://dx.doi.org/10.1007/s00399-019-0633-z] [PMID: 31396698]
[60]
Semler MW, Wheeler AP. Slow and study: Support for a randomized trial of β-blockade in sepsis-associated atrial fibrillation. Chest 2016; 149(1): 9-10.
[http://dx.doi.org/10.1016/j.chest.2015.08.020] [PMID: 26757282]
[61]
Desai R, Hanna B, Singh S, et al. Trends and outcomes in sepsis hospitalizations with and without atrial fibrillation: A nationwide inpatient analysis. Crit Care Med 2019; 47(8): e630-8.
[http://dx.doi.org/10.1097/CCM.0000000000003806] [PMID: 31094740]
[62]
Lubitz SA, Yin X, Rienstra M, et al. Long-term outcomes of secondary atrial fibrillation in the community: The Framingham Heart Study. Circulation 2015; 131(19): 1648-55.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014058] [PMID: 25769640]
[63]
Klein Klouwenberg PM, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. a cohort study. Am J Respir Crit Care Med 2017; 195(2): 205-11.
[http://dx.doi.org/10.1164/rccm.201603-0618OC] [PMID: 27467907]
[64]
Meierhenrich R, Steinhilber E, Eggermann C, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: A prospective observational study. Crit Care 2010; 14(3): R108.
[http://dx.doi.org/10.1186/cc9057] [PMID: 20537138]
[65]
Arora S, Lang I, Nayyar V, Stachowski E, Ross DL. Atrial fibrillation in a tertiary care multidisciplinary intensive care unit--incidence and risk factors. Anaesth Intensive Care 2007; 35(5): 707-13.
[http://dx.doi.org/10.1177/0310057X0703500508] [PMID: 17933156]
[66]
Shaver CM, Chen W, Janz DR, et al. Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med 2015; 43(10): 2104-11.
[http://dx.doi.org/10.1097/CCM.0000000000001166] [PMID: 26154932]
[67]
Lardaro T, Self WH, Barrett TW. Thirty-day mortality in ED patients with new onset atrial fibrillation and actively treated cancer. Am J Emerg Med 2015; 33(10): 1483-8.
[http://dx.doi.org/10.1016/j.ajem.2015.07.033] [PMID: 26283615]
[68]
Salman S, Bajwa A, Gajic O, Afessa B. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 2008; 23(3): 178-83.
[http://dx.doi.org/10.1177/0885066608315838] [PMID: 18443011]
[69]
Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 2011; 306(20): 2248-54.
[http://dx.doi.org/10.1001/jama.2011.1615] [PMID: 22081378]
[70]
Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: A propensity-matched cohort study. Chest 2016; 149(1): 74-83.
[http://dx.doi.org/10.1378/chest.15-0959] [PMID: 26270396]
[71]
Gandhi S, Litt D, Narula N. New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality. Neth Heart J 2015; 23(2): 82-8.
[http://dx.doi.org/10.1007/s12471-014-0641-x] [PMID: 25573848]
[72]
Tingting HE, Xiao K, Liu Q, Wang T, Jia R. Correlation of inflammatory cytokine interleukin 1β interleukin 33 and neutrophil to lymphocyte ratio with atrial fibrillation. Clinical Medicine of China 2017; 33(9): 786-9.
[73]
Yoshida T, Fujii T, Uchino S, Takinami M. Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: A systematic review. J Intensive Care 2015; 3(1): 19.
[http://dx.doi.org/10.1186/s40560-015-0085-4] [PMID: 25914828]
[74]
Amdur RL, Mukherjee M, Go A, et al. Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: Findings from the CRIC study. PLoS One 2016; 11(2): e0148189.
[http://dx.doi.org/10.1371/journal.pone.0148189] [PMID: 26840403]
[75]
Weymann A, Popov AF, Sabashnikov A, et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: A systematic review and meta-analysis. Kardiol Pol 2018; 76(2): 440-51.
[http://dx.doi.org/10.5603/KP.a2017.0242] [PMID: 29354906]
[76]
Aulin J, Siegbahn A, Hijazi Z, et al. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J 2015; 170(6): 1151-60.
[http://dx.doi.org/10.1016/j.ahj.2015.09.018] [PMID: 26678637]
[77]
Chang TY, Chao TF, Liu CJ, et al. The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study. Heart Rhythm 2016; 13(6): 1189-94.
[http://dx.doi.org/10.1016/j.hrthm.2016.01.026] [PMID: 26850784]
[78]
De Caterina R, Ruigómez A, Rodríguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med 2010; 170(16): 1450-5.
[http://dx.doi.org/10.1001/archinternmed.2010.305] [PMID: 20837831]
[79]
Rahman F, Ko D, Benjamin EJ. Association of atrial fibrillation and cancer. JAMA Cardiol 2016; 1(4): 384-6.
[http://dx.doi.org/10.1001/jamacardio.2016.0582] [PMID: 27438312]
[80]
Mathur P, Paydak H, Thanendrarajan S, van Rhee F. Atrial fibrillation in hematologic malignancies, especially after autologous hematopoietic stem cell transplantation: Review of risk factors, current management, and future directions. Clin Lymphoma Myeloma Leuk 2016; 16(2): 70-5.
[http://dx.doi.org/10.1016/j.clml.2015.10.001] [PMID: 26776085]
[81]
Ostenfeld EB, Erichsen R, Pedersen L, Farkas DK, Weiss NS, Sørensen HT. Atrial fibrillation as a marker of occult cancer. PLoS One 2014; 9(8): e102861.
[http://dx.doi.org/10.1371/journal.pone.0102861] [PMID: 25119880]
[82]
Muranishi Y, Sonobe M, Menju T, et al. Atrial fibrillation after lung cancer surgery: Incidence, severity, and risk factors. Surg Today 2017; 47(2): 252-8.
[http://dx.doi.org/10.1007/s00595-016-1380-y] [PMID: 27382978]
[83]
Seesing MFJ, Borggreve AS, Ruurda JP, van Hillegersberg R. New-onset atrial fibrillation after esophagectomy for cancer. J Thorac Dis 2019; 11(5) (Suppl. 5): S831-4.
[http://dx.doi.org/10.21037/jtd.2019.02.03] [PMID: 31080666]
[84]
Higuchi S, Kabeya Y, Matsushita K, et al. Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy. PLoS One 2019; 14(5): e0216239.
[http://dx.doi.org/10.1371/journal.pone.0216239] [PMID: 31063466]
[85]
Abdel-Qadir H, Thavendiranathan P, Fung K, et al. Association of early-stage breast cancer and subsequent chemotherapy with risk of atrial fibrillation. JAMA Netw Open 2019; 2(9): e1911838.
[http://dx.doi.org/10.1001/jamanetworkopen.2019.11838] [PMID: 31539076]
[86]
Yang X, Li X, Yuan M, et al. Anticancer therapy-induced atrial fibrillation: Electrophysiology and related mechanisms. Front Pharmacol 2018; 9: 1058.
[http://dx.doi.org/10.3389/fphar.2018.01058] [PMID: 30386232]
[87]
Yun S, Vincelette ND, Acharya U, Abraham I. Risk of atrial fibrillation and bleeding diathesis associated with ibrutinib treatment: A systematic review and pooled analysis of four randomized controlled trials. Clin Lymphoma Myeloma Leuk 2017; 17(1): 31-37.e13.
[http://dx.doi.org/10.1016/j.clml.2016.09.010] [PMID: 27780690]
[88]
Manolis AA, Manolis TA, Mikhailidis DP, Manolis AS. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1. Expert Opin Drug Saf 2018; 17(9): 875-92.
[http://dx.doi.org/10.1080/14740338.2018.1513488] [PMID: 30126304]
[89]
Manolis AA, Manolis TA, Mikhailidis DP, Manolis AS. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - Part 2. Expert Opin Drug Saf 2018; 17(9): 893-915.
[http://dx.doi.org/10.1080/14740338.2018.1513489] [PMID: 30126303]
[90]
O’Neal WT, Lakoski SG, Qureshi W, et al. Relation between cancer and atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study). Am J Cardiol 2015; 115(8): 1090-4.
[http://dx.doi.org/10.1016/j.amjcard.2015.01.540] [PMID: 25711434]
[91]
Yuan M, Zhang Z, Tse G, et al. Association of cancer and the risk of developing atrial fibrillation: a systematic review and meta-analysis. Cardiol Res Pract 2019; 2019: 8985273.
[http://dx.doi.org/10.1155/2019/8985273] [PMID: 31110819]
[92]
Marwaha B, Shah J, Changal K, et al. Incidence of new onset atrial fibrillation in lung cancer patients. Circulation 2018; 138(1): A16937.
[93]
Yandrapalli S, Malik A, Atuh G, et al. Prevalence and impact of atrial fibrillation in hospitalized solid organ cancer patients. Circulation 2019; 140(1): A16605.
[94]
Nouraie M, Kansal V, Belfonte C, et al. Atrial fibrillation and colonic neoplasia in African Americans. PLoS One 2015; 10(8): e0135609.
[http://dx.doi.org/10.1371/journal.pone.0135609] [PMID: 26317627]
[95]
Guzzetti S, Costantino G, Vernocchi A, Sada S, Fundarò C. First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation. Intern Emerg Med 2008; 3(3): 227-31.
[http://dx.doi.org/10.1007/s11739-008-0124-4] [PMID: 18320149]
[96]
Hu YF, Liu CJ, Chang PM, et al. Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol 2013; 165(2): 355-7.
[http://dx.doi.org/10.1016/j.ijcard.2012.08.036] [PMID: 22989607]
[97]
Erichsen R, Christiansen CF, Mehnert F, Weiss NS, Baron JA, Sørensen HT. Colorectal cancer and risk of atrial fibrillation and flutter: A population-based case-control study. Intern Emerg Med 2012; 7(5): 431-8.
[http://dx.doi.org/10.1007/s11739-011-0701-9] [PMID: 21968511]
[98]
Sorigue M, Gual-Capllonch F, Garcia O, et al. Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma. Ann Hematol 2018; 97(9): 1633-40.
[http://dx.doi.org/10.1007/s00277-018-3346-1] [PMID: 29728734]
[99]
Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L. Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg 2012; 7(1): 4.
[http://dx.doi.org/10.1186/1749-8090-7-4] [PMID: 22233837]
[100]
Guha A, Dey AK, Jneid H, Ibarz JP, Addison D, Fradley M. Atrial fibrillation in the era of emerging cancer therapies. Eur Heart J 2019; 40(36): 3007-10.
[http://dx.doi.org/10.1093/eurheartj/ehz649] [PMID: 31541552]
[101]
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140(6): 883-99.
[http://dx.doi.org/10.1016/j.cell.2010.01.025] [PMID: 20303878]
[102]
Conen D, Wong JA, Sandhu RK, et al. Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol 2016; 1(4): 389-96.
[http://dx.doi.org/10.1001/jamacardio.2016.0280] [PMID: 27438314]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy